Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
IG Mackenzie Global Health Care Fund Series B
Health Care Equity
Click for more information on Fundata’s FundGrade
FundGrade C
Click for more information on Fundata’s FundGrade.
Click for more information on Fundata’s ESG Grade
Fundata ESG Grade A
Click for more information on Fundata’s ESG Grade.
|
NAVPS (08-14-2026) |
$45.77 |
|---|---|
| Change |
-$0.49
(-1.06%)
|
As at July 31, 2026
As at May 31, 2026
As at July 31, 2026
Loading......
Legend
Compare Options
Fund Returns
Inception Return (October 24, 2002): 6.88%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | 1.40% | 11.98% | 7.68% | 8.22% | 26.42% | 4.13% | 7.39% | 6.74% | 5.47% | 6.50% | 8.52% | 7.64% | 7.78% | 6.92% |
| Benchmark | 0.29% | 11.32% | 5.64% | 5.90% | 21.63% | 5.18% | 9.21% | 8.52% | 5.90% | 7.12% | 9.27% | 8.61% | 9.70% | 8.82% |
| Category Average | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Category Rank | 19 / 55 | 30 / 55 | 14 / 53 | 14 / 53 | 19 / 53 | 25 / 52 | 25 / 50 | 19 / 43 | 13 / 41 | 18 / 40 | 12 / 37 | 14 / 36 | 15 / 31 | 13 / 29 |
| Quartile Ranking | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Monthly Return
| Return % | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 5.41% | 2.71% | 2.68% | 7.67% | -2.39% | 0.50% | 4.41% | -6.56% | -1.44% | 2.74% | 7.49% | 1.40% |
| Benchmark | 4.16% | 2.38% | 3.42% | 7.21% | -2.85% | 0.25% | 3.41% | -6.17% | -2.20% | 3.08% | 7.68% | 0.29% |
Best Monthly Return Since Inception
10.47% (January 2015)
Worst Monthly Return Since Inception
-8.28% (September 2008)
Calendar Return (%)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -10.26% | 8.60% | 5.95% | 14.48% | 11.18% | 18.51% | 0.49% | -1.00% | 4.42% | 7.29% |
| Benchmark | -8.68% | 14.01% | 11.82% | 17.06% | 13.59% | 15.28% | -1.72% | 1.42% | 9.95% | 9.64% |
| Category Average | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | 2 | 4 | 3 | 3 | 3 | 2 | 2 | 4 | 3 | 3 |
| Category Rank | 11/ 29 | 22/ 29 | 20/ 34 | 25/ 36 | 19/ 37 | 18/ 40 | 17/ 42 | 35/ 43 | 34/ 50 | 33/ 52 |
Best Calendar Return (Last 10 years)
18.51% (2021)
Worst Calendar Return (Last 10 years)
-10.26% (2016)
Asset Allocation
| Name | Percent |
|---|---|
| US Equity | 69.97 |
| International Equity | 29.73 |
| Cash and Equivalents | 0.28 |
| Other | 0.02 |
Sector Allocation
| Name | Percent |
|---|---|
| Healthcare | 98.99 |
| Consumer Services | 0.52 |
| Cash and Cash Equivalent | 0.28 |
| Consumer Goods | 0.10 |
| Technology | 0.08 |
| Other | 0.03 |
Geographic Allocation
| Name | Percent |
|---|---|
| North America | 70.25 |
| Europe | 23.87 |
| Asia | 4.92 |
| Africa and Middle East | 0.94 |
| Other | 0.02 |
Top Holdings
| Name | Percent |
|---|---|
| Eli Lilly and Co | 10.56 |
| Johnson & Johnson | 6.24 |
| UnitedHealth Group Inc | 5.63 |
| Roche Holding AG | 5.41 |
| Novartis AG Cl N | 4.69 |
| Abbvie Inc | 4.16 |
| Amgen Inc | 3.33 |
| Gilead Sciences Inc | 3.15 |
| Merck & Co Inc | 3.04 |
| AstraZeneca PLC | 2.95 |
Equity Style
Fixed Income Style
Risk vs Return (3 Yr)
IG Mackenzie Global Health Care Fund Series B
Median
Other - Health Care Equity
3 Yr Annualized
| Standard Deviation | 13.12% | 12.69% | 11.77% |
|---|---|---|---|
| Beta | 1.08 | 1.02 | 0.98 |
| Alpha | -0.02 | 0.00 | -0.02 |
| Rsquared | 0.96% | 0.94% | 0.94% |
| Sharpe | 0.35 | 0.25 | 0.46 |
| Sortino | 0.59 | 0.37 | 0.58 |
| Treynor | 0.04 | 0.03 | 0.06 |
| Tax Efficiency | 97.58% | 96.30% | 96.94% |
| Volatility |
|
|
|
Risk Rating
Annualized Key Ratio Period Comparison
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 14.33% | 13.12% | 12.69% | 11.77% |
| Beta | 1.00 | 1.08 | 1.02 | 0.98 |
| Alpha | 0.04 | -0.02 | 0.00 | -0.02 |
| Rsquared | 0.98% | 0.96% | 0.94% | 0.94% |
| Sharpe | 1.56 | 0.35 | 0.25 | 0.46 |
| Sortino | 2.88 | 0.59 | 0.37 | 0.58 |
| Treynor | 0.22 | 0.04 | 0.03 | 0.06 |
| Tax Efficiency | 100.00% | 97.58% | 96.30% | 96.94% |
Fundata ESG Metrics
Fundata ESG Score
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Fundata E Score
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Fundata S Score
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Fundata G Score
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
Fund Details
| Start Date | October 24, 2002 |
|---|---|
| Instrument Type | Mutual Fund |
| Share Class | Commission Based Advice |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | $344 |
Fund Codes
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| IGI1947 |
Investment Objectives
The Class aims to provide long-term capital growth by investing in the common shares of global corporations engaged in the development, production or distribution of products and services related to the treatment or prevention of medical diseases or other medical-related problems.
Investment Strategy
The Class will: invest in various health care sub-sectors, health care services and biotechnology; employ a stock selection process driven by a combined approach to fundamental scientific and quantitative analysis; invest in corporations that have strong management teams, are well-established and have favourable earnings outlooks; allocate a portion of the Class to more innovative corporations with faster growth profiles.
Portfolio Management
| Portfolio Manager |
I.G. Investment Management, Ltd. |
|---|---|
| Sub-Advisor |
Mackenzie Financial Corporation
|
Management and Organization
| Fund Manager |
I.G. Investment Management, Ltd. |
|---|---|
| Custodian |
Canadian Imperial Bank of Commerce |
| Registrar |
I.G. Investment Management, Ltd. |
| Distributor |
Investors Group Financial Services Inc. Investors Group Securities Inc. |
Investment Minimums
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | - |
| PAC Subsequent | - |
| SWP Allowed | Yes |
| SWP Min Balance | - |
| SWP Min Withdrawal | 50 |
Fees
| MER | 2.75% |
|---|---|
| Management Fee | 1.95% |
| Load | No Load |
| FE Max | - |
| DSC Max | - |
| Trailer Fee Max (FE) | - |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | 0.70% |
| Trailer Fee Max (LL) | - |
Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
